Emerson reports first quarter 2023 results; updates 2023 outlook

Net sales were $3.4 billion, up 7 percent from the year prior; underlying sales1 were up 6 percent strong operational performance to start 2023 offset by foreign exchange and stock compensation headwinds gaap eps was $0.56; adjusted eps2 was $0.78, including $0.09 unfavorable impact from stock compensation completed $2 billion of share repurchase in the first quarter updated 2023 full year net sales and gaap eps outlook; maintained underlying sales and adjusted eps outlook despite stock compensation headwind announced st. louis selected as global headquarters declared quarterly cash dividend of $0.52 per share of common stock payable march 10, 2023 to stockholders of record february 17, 2023 st. louis , feb. 8, 2023 /prnewswire/ -- emerson (nyse: emr) today reported results for its first quarter ended december 31, 2022 and updated its full year outlook for fiscal 2023, which are presented on a continuing operations basis.
EMR Ratings Summary
EMR Quant Ranking